Is Panbela Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: PBLA) stock is to Strong Buy PBLA stock.
Out of 2 analysts, 2 (100%) are recommending PBLA as a Strong Buy, 0 (0%) are recommending PBLA as a Buy, 0 (0%) are recommending PBLA as a Hold, 0 (0%) are recommending PBLA as a Sell, and 0 (0%) are recommending PBLA as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year PBLA price target, the average PBLA price target is $5.75, with the highest PBLA stock price forecast at $10.00 and the lowest PBLA stock price forecast at $1.50.
On average, Wall Street analysts predict that Panbela Therapeutics's share price could reach $5.75 by Mar 20, 2024. The average Panbela Therapeutics stock price prediction forecasts a potential upside of 1,047.7% from the current PBLA share price of $0.50.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.